Inhibitor Therapeutics, Inc. Notes Payable, Current
Inhibitor Therapeutics, Inc. (INTI) had Notes Payable, Current of $411.00 thousand as of 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2024-03-29
- 2022-12-31: Notes Payable, Current $411.00K.
- 2014-09-30: Notes Payable, Current $41.92K.
- 2014-06-30: Notes Payable, Current $102.42K.
- 2014-03-31: Notes Payable, Current $77.70K.
| Period end | Notes Payable, Current |
|---|---|
| 2022-12-31 | $411.00K 10-K · filed 2024-03-29 |
| 2014-09-30 | $41.92K 10-Q · filed 2014-10-10 |
| 2014-06-30 | $102.42K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $77.70K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $68.43K 10-Q · filed 2014-10-10 |